36 results on '"Janssen, Harry L.A."'
Search Results
2. Aiming for Functional Cure With Established and Novel Therapies for Chronic Hepatitis B.
3. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America.
4. Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time.
5. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy.
6. Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase.
7. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes.
8. Microbiomics, Metabolomics, Predicted Metagenomics, and Hepatic Steatosis in a Population‐Based Study of 1,355 Adults.
9. Real‐World Effectiveness of Obeticholic Acid in Patients with Primary Biliary Cholangitis.
10. Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference.
11. Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B.
12. Entecavir and Peginterferon Alfa‐2a in Adults With Hepatitis B e Antigen–Positive Immune‐Tolerant Chronic Hepatitis B Virus Infection.
13. Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease.
14. Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
15. Letter to the Editor: Entecavir Treatment Restores the Anti‐HBV Immune response?
16. Diabetes and prediabetes in patients with hepatitis B residing in North America.
17. Re-evaluation of hepatitis B virus clinical phases by systems biology identifies unappreciated roles for the innate immune response and B cells.
18. Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).
19. Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels.
20. Good long-term outcome of Budd-Chiari syndrome with a step-wise management.
21. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
22. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
23. Idiopathic noncirrhotic portal hypertension.
24. Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
25. Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
26. Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
27. Patterns of viral decline during PEG-interferon alpha-2b therapy in HBeAg-positive chronic hepatitis B: Relation to treatment response.
28. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity.
29. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
30. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome.
31. Relapse of chronic hepatitis B after discontinuation of nucleos(t)ide analogs: Is the glass half full or half empty?
32. Reply.
33. Ribavirin enhances interferon-stimulated gene transcription by activation of the interferon-stimulated response element.
34. Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype.
35. Reply.
36. Chronic hepatitis B: HBeAg seroconversion after pegylated interferon and nucleos(t)ide analogs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.